Methods and compositions for the treatment of CNS-related conditions
First Claim
Patent Images
1. A pharmaceutical composition comprising:
- (a) an NMDA receptor antagonist;
(b) a second agent, wherein said agent is a monoamine oxidase (MAO) inhibitor or a GADPH inhibitor; and
(c) a pharmaceutically acceptable carrier wherein said NMDA receptor antagonist, said second agent, or both are in an extended release dosage form.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides methods and compositions for the treatment of dementia-related conditions, such as Parkinson'"'"'s disease and Alzheimer'"'"'s disease.
-
Citations
56 Claims
-
1. A pharmaceutical composition comprising:
-
(a) an NMDA receptor antagonist;
(b) a second agent, wherein said agent is a monoamine oxidase (MAO) inhibitor or a GADPH inhibitor; and
(c) a pharmaceutically acceptable carrier wherein said NMDA receptor antagonist, said second agent, or both are in an extended release dosage form. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 36, 37)
-
- 27. A method of treating a CNS-related condition comprising administering to a subject in need thereof a therapeutically effective amount of a combination comprising an NMDA receptor antagonist and a second agent, wherein said second agent is a MAO inhibitor or a GADPH inhibitor.
Specification